

[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
Andrew Fein Reiterated (UTHR) at Strong Buy and Held Target at $300 on, Feb 22nd, 2024
Andrew Fein of HC Wainwright & Co., Reiterated "United Therapeutics Corporation" (UTHR) at Strong Buy and Held Target at $300 on, Feb 22nd, 2024.
Andrew has made no other calls on UTHR in the last 4 months.
There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Chris Shibutani of "Goldman Sachs" Upgraded from Strong Sell to Hold and Increased Target to $215 on, Monday, February 12th, 2024
These are the ratings of the 3 analyists that currently disagree with Andrew
- Roanna Ruiz of "Leerink Partners" Initiated at Buy and Held Target at $330 on, Monday, February 5th, 2024
- Terence Flynn of "Morgan Stanley" Maintained at Buy with Decreased Target to $314 on, Thursday, November 2nd, 2023
- Jessica Fung of "JP Morgan" Maintained at Buy with Increased Target to $294 on, Thursday, November 2nd, 2023
Contributing Sources